Larimar Therapeutics LRMR
NASDAQ LRMR
$2.96 -0.10 (-3.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Larimar Therapeutics' Return on Capital Employed [ROCE] came in at -144.69% for Q2 2026, down 63.35 percentage points from -81.34% a year earlier.

Analysis

Larimar Therapeutics (LRMR) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Larimar Therapeutics' Return on Capital Employed [ROCE] was -159.37%, down 85.91 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last three years, with a five-year change of -66.22 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -73.46% in FY2024 (-32.39 pp), -41.07% in FY2023 (-1.30 pp), -39.78% in FY2022 (+21.15 pp) and -60.93% in FY2021 (+32.22 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -169.45% (Q4 2025) to -29.72% (Q2 2024).
  • Year-over-year, Return on Capital Employed [ROCE] increased in 1 of the last seven quarters, with an average year-over-year change of -49.50 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2023 (a gain of 40.74 percentage points), and the weakest in Q4 2025 (a drop of 120.39 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Larimar Therapeutics 317.88 Mn -289.20 Mn - -144.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144.69%
Dec 31, 2025 -169.45%
Sep 30, 2025 -113.13%
Jun 30, 2025 -81.34%
Mar 31, 2025 -64.60%
Dec 31, 2024 -49.06%
Sep 30, 2024 -34.82%
Jun 30, 2024 -29.72%
Mar 31, 2024 -31.94%
Dec 31, 2023 -46.17%
Sep 30, 2023 -37.56%
Jun 30, 2023 -33.52%
Mar 31, 2023 -30.77%
Dec 31, 2022 -30.69%
Sep 30, 2022 -39.74%
Jun 30, 2022 -73.15%
Mar 31, 2022 -71.51%
Dec 31, 2021 -67.78%
Sep 30, 2021 -75.24%
Jun 30, 2021 -62.28%
API Access

Larimar Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LRMR&period=max&api_key=YOUR_API_KEY